Read publication 

The OTC derivative regulatory regime in Hong Kong is being implemented in phases. This briefing is designed to update market participants on the aspects of the regime which have been implemented, those that will be implemented on 1 July 2017 and those that have been announced and are waiting implementation.

This briefing is intended to serve as a high level overview of the key aspects of the OTC derivative regulatory regime in Hong Kong and is not an exhaustive list of all the obligations and requirements which may be applicable to your organisation.

Explore More Insight
View All